Principales Publications Scientifiques depuis 2018

Nature Springer.png

Argote M, Sescousse G, Brunelin J, Fakra E, Nourredine M, Rolland B

Association between formal thought disorder and cannabis use: a systematic review and meta-analysis Schizophrenia volume 8, Article number: 78 (2022)


Fovet T, Wathelet M, Benbouriche M, Benradia I, Roelandt JL, Thomas P, d'Hondt F, Rolland B

Substance use, substance use disorders, and co-occurring psychiatric disorders in recently incarcerated men: a comparison with the general population. Eur Addict Res 2022


Lespine LF, Bramness JG, Pignon B, Vaiva G, Thomas P, Roelandt JL, Benradia I, Amad A, Geoffroy PA, Rolland B. Gender-related Associations between Psychiatric Disorders and Alcohol Use Disorder: Findings from The French "Mental Health in the General Population" Survey. Arch Womens Ment Health 2022


Carton L, Icick R, Weibel S, Dematteis M, Kammerer E, Batisse A, Rolland B; French coordination for adult ADHD.  What is the potential for abuse of lisdexamfetamine in adults? A preclinical and clinical literature review and expert opinion. Expert Rev Clin Pharmacol 2022 Aug.
doi: 10.1080/17512433.2022.211295

Liver int.jpg

Louvet A, Trabut JB, Moreno C, Moirand R, Aubin HJ, Ntandja Wandji LC, Nourredine M, Ningarhari M, Ganne-Carrié N, Pageaux GP, Bailly F, [...], Mathurin P, Rolland B; for the Groupe collaboratif AFEF-SFA Maladie du foie liée à l'alcool. Management of alcohol-related liver disease: the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines. Liver Int. 2022 Jun;42(6):1330-1343.


de Ternay J, Leblanc P, Michel P, Benyamina A, Naassila M, Rolland B.

One-month alcohol abstinence national campaigns: a scoping review of the harm reduction benefits.

Harm Reduct J. 2022 Mar 4;19(1):24. doi: 10.1186/s12954-022-00603-x


Chapron SA, Nourredine M, Dondé C, Haesebaert F, Micoulaud-Franchi JA, Geoffroy PA, Rolland B. Efficacy and safety of topiramate for reducing impulsivity: A transdiagnostic systematic review and meta-analysis of a common clinical use. Fundam Clin Pharmacol. 2021 Jul 1.doi: 10.1111/fcp.12710.

Dove press.jpg

Chappuy M, Meroueh F, Trojak B, Bachellier J, Bendimerad P, Kosim M, Hjelmström P, Nubukpo P, Brousse G, Rolland B. Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder. Patient Prefer Adherenc. 2021 Jun 14;15:1259-1267.

JAMA Psychiatry_cover_y0313.png

Nourredine M, Gering A, Fourneret P, Rolland B, Falissard B, Cucherat M, Geoffray MM, Jurek L..

Association of Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence With the Risk of Subsequent Psychotic Disorder: A Systematic Review and Meta-analysis.
JAMA Psychiatry. 2021 May 1;78(5):519-529


Luquiens A, Berger-Viergat A, Larrieu A, Artigaud L, Fener C, Adamson S, Laprévote V, Rolland B.

Validation of the French version of the Cannabis Use Disorder Identification Test-Revised and comparison with the Cannabis Abuse Screening Test for screening cannabis use disorder in a psychiatric sample.
Drug Alcohol Rev. 2021; doi: 10.1111/dar.13298


Rolland B, Trojak B, Nourredine M, Bachellier J, Chappuy M, Bendimerad P, Kosim M, Hjelmström P, Meroueh F, Nubukpo P, Brousse G.
Determinants of interest in extended-released buprenorphine: A survey among 366 French patients treated with buprenorphine or methadone.

Drug Alcohol Depend. 2021; 220:108492.


Bertin C, Delage N, Rolland B, Pennel L, Fatseas M, Trouvin AP, Delorme J, Chenaf C, Authier N.
Analgesic opioid use disorder in patients with chronic non-cancer pain: A holistic approach for tailored management

Neurosci Biobehav Rev. 2021; 121:160-174.


Fourneret P, Zimmer L, Rolland B.
How to improve in France ADHD transition support from childhood to adulthood

Encephale. 2020; S0013-7006(20)30238-4.

J Psychiatric Research.jpg

Pabst A, Peyroux E, Rolland B, de Timary P, Maurage P
Hostile attributional bias in severe alcohol use disorder

J Psychiatr Res. 2020; 129:176-180.


Dondé C, Brunelin J, Mondino M, Cellard C, Rolland B, Haesebaert F.
The effects of acute nicotine administration on cognitive and early sensory processes in schizophrenia: a systematic review

Neurosci Biobehav Rev. 2020; 118:121-133.


Rolland B, Haesebaert F, Zante E, Benyamina A, Haesebaert J, Franck N. 
Global changes and factors of increase in caloric/salty food, screen, and substance use, during the early COVID-19 containment phase in France: a general population online survey

JMIR Public Health Surveill. 2020; doi: 10.2196/19630.


Chappuy M, Trojak B, Nubukpo P, Bachellier J, Bendimerad P, Brousse G, Rolland B.
Prolonged-release buprenorphine formulations: perspectives for clinical practice

Therapies. 2020;

SiH Logo.jpg

Gelis A, Cervello S, Rey R, Llorca G, Lambert P, Franck N, Dupeyron A, Delpont M, Rolland B.
Peer Role-Play for Training Communication Skills in Medical Students: A Systematic Review.

Simul Healthc. 2020; doi: 10.1097/SIH.0000000000000412


Geoffroy PA, Lejoyeux M, Rolland B.
Management of insomnia in alcohol use disorder.

Expert Opin Pharmacother. 2020; 21(3):297-306. doi: 10.1080/14656566.2019.1705279.

Cover Lancet 2020.jpg

Chappuy M, Boulanger A, Nourredine M, Fourneret P, Rolland B.
Disparate regulatory status of methylphenidate for adults with ADHD across Europe.

Lancet Psychiatry. 2020; 7(1):e1-e2. doi: 10.1016/S2215-0366(19)30482-1.

Progress in Neuropsychopharmacology.jpg

Meyrel M, Rolland B, Geoffroy PA.
Alterations in circadian rhythms following alcohol use: A systematic review.

Prog Neuropsychopharmacol Biol Psychiatry. 2020; 99:109831. doi: 10.1016/j.pnpbp.2019.109831.

Capture d'écran 2019-10-29 20.59.51.png

Rolland B, Simon N, Franchitto N, Aubin HJ.
France Grants an Approval to Baclofen for Alcohol Dependence.

Alcohol Alcohol. 2020; 55(1):44-45. doi: 10.1093/alcalc/agz082.

Capture d'écran 2019-10-29 20.59.51.png

Pignon B, Sescousse G, Amad A, ..., Roelandt JL, Rolland B.
Alcohol Use Disorder Is Differently Associated With Psychotic Symptoms According To Underlying Psychiatric Disorders: A General Population Study.

Alcohol Alcohol. 2020; 55(1):112-120. doi: 10.1093/alcalc/agz077


Li Y, Wang Z, Boileau I, Dreher JC, ..., van Timmeren T, Sescousse G
Altered orbitofrontal sulcogyral patterns in gambling disorder: a multicenter study.

Transl Psychiatry. 2019; 9(1):186. doi: 10.1038/s41398-019-0520-8


Vorspan F, Hjelmström P, Simon N, ..., Kosim M, Rolland B
What place for prolonged-release buprenorphine depot formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine.

Expert Opin Drug Deliv. 2019. 16(9):907-914. doi: 10.1080/17425247.2019.1649252.


Carton L, Auger F, Kyheng M, ..., Bordet R, Rolland B
Dose-dependent metabolite changes after ethanol intoxication in rat prefrontal cortex using in vivo magnetic resonance spectroscopy.

Sci Rep. 2019; 9(1):10682. doi: 10.1038/s41598-019-47187-4.

Capture d'écran 2019-06-23 20.18.21.png

De Ternay J, Naassila M, Nourredine M, Louvet A, Bailly F, Sescousse G, Maurage P, Cottencin O, Carrieri PM, Rolland B.
Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain.

Front Pharmacol. 2019; 10:627. doi: 10.3389/fphar.2019.00627.


Mas-Herrero E, Sescousse G, Cools R, Marco-Pallarés J.
The contribution of striatal pseudo-reward prediction errors to value-based decision-making. 
Neuroimage. 2019; 193:67-74.doi: 10.1016/j.neuroimage.2019.02.052.


Lenglard F, Berger-Vergiat A, Ragonnet D, Duvernay N, Lack P, Poulet E, Zoulim F, Chappuy M.

Retour d'expérience de deux CSAPA et enquête nationale sur la naloxone intranasale (Nalscue®) dans la prévention des overdoses aux opioïdes

Thérapie. 2019; 74(4):477-486.


Agabio R, Sinclair JM, Addolorato G, ..., Rolland B, Stafford A, Thompson A, van den Brink W, de Beaurepaire R, Leggio L. 
Baclofen for the treatment of alcohol use disorder: the Cagliari Statement. 
Lancet Psychiatry. 2018; 5(12):957-960.


Simon N, Moirand R, Dematteis M, Bordet R, Deplanque D, Rolland B.
Full-Profile Pharmacokinetic Study of High Dose Baclofen in Subjects With Alcohol Use Disorder.

Front Psychiatry. 2018; 9:385.